Concerns & Risks -- 7/10
A score of 7 reflects a favorable risk/reward profile with manageable downside risks. BLK
trades at a ~78% premium to traditional asset management peers on forward P/E (17.8x vs ~10x),
but this premium is structurally justified by dominant scale ($14T+ AUM), superior organic
growth (12% base fee organic growth in Q4 2025), an expanding private markets franchise
(GIP/HPS/Preqin), and the Aladdin technology platform. China exposure is negligible at less
than 2% of AUM. The primary risk is market beta -- at 1.49, BLK amplifies equity market
drawdowns, and AUM at record levels means fees are also at record levels. The stock is -21%
from its 52-week high, compressing the valuation premium to the lower end of its historical range.
Weight: 15%
Fwd P/E (NTM)
17.8x
Peer avg ~10x; premium justified by quality
EV/EBITDA (NTM)
17.2x
Peer avg ~10-12x
China AUM %
<2%
Negligible revenue exposure
Beta
1.49
Amplifies market drawdowns
Valuation snapshot
| Metric |
Value |
Source / Note |
| Stock Price |
$967 |
-21% from 52-week high; GF Value $1,081 (Modestly Undervalued) |
| Forward P/E (NTM) |
17.8x |
Peer avg ~10x (TROW 8.9x, IVZ 9.1x, STT 11.9x) |
| P/B |
2.82x |
Peer avg ~1.5-2.0x; +117% premium |
| EV / EBITDA (NTM) |
17.2x |
Peer avg ~10-12x; premium reflects Aladdin + private markets |
| FY2025 Revenue |
$24.22B |
+18.7% YoY vs FY2024 $20.41B |
| FY2026E Revenue |
~$28.3B |
Consensus; +17% YoY |
| FY2026E EPS (Consensus) |
~$54.42 |
18 analysts; implies 17.8x fwd P/E at $967 |
| Adj Operating Margin (FY25) |
44.1% |
Q4 2025 adj margin 45.0% -- highest of the year |
| Total AUM |
$14.04T |
Record level; Q4 net inflows $281B |
| Share Buybacks (Annual) |
~$1.5B |
Modest relative to ~$140B market cap |
FY2025 financial recap
| Metric |
2024FY |
2025Q1 |
2025Q2 |
2025Q3 |
2025Q4 |
2025FY |
| Revenue ($M) |
$20,407 |
$5,276 |
$5,423 |
$6,509 |
$7,008 |
$24,216 |
| GAAP Op Margin |
37.1% |
32.2% |
31.9% |
30.0% |
23.7% |
29.1% |
| Adj Op Margin |
44.5% |
43.2% |
43.3% |
44.6% |
45.0% |
44.1% |
| Total AUM ($M) |
11,551,251 |
11,186,172 |
11,580,761 |
12,081,300 |
12,603,633 |
12,603,633 |
Q4 2025 GAAP margin of 23.7% depressed by GIP/HPS/Preqin acquisition-related charges.
Adjusted margin of 45.0% was the year high, demonstrating underlying operating leverage.
Total AUM including cash management ended 2025 at $14.04T.
Peer valuation comparison
| Company |
Ticker |
Fwd P/E |
P/B |
Notes |
| BlackRock |
BLK |
17.8x |
2.82x |
Premium justified by scale, growth, Aladdin |
| T. Rowe Price |
TROW |
8.9x |
2.1x |
Active-only, no ETFs, declining AUM trends |
| Invesco |
IVZ |
9.1x |
0.7x |
Turnaround story, lower margins |
| State Street |
STT |
11.9x |
1.1x |
Custody + asset mgmt, lower organic growth |
| Peer Average (ex-BLK) |
|
~10.0x |
~1.3x |
BLK at +78% P/E premium, +117% P/B premium |
BLK trades at a ~78% premium to the traditional asset management peer group on forward P/E.
This premium has historically ranged from 50-100%, so the current level is within the normal
band. The premium reflects dominant ETF franchise, Aladdin technology platform, and now
private markets scale via GIP/HPS/Preqin.
China exposure -- low concern
Direct China exposure is negligible. Asia-Pacific represents ~7% of total AUM
(~$880B of $12.6T), with China estimated at less than 2% of total AUM based on fund-level
disclosures. The House Select Committee on the CCP flagged ~$1.9B of BlackRock investments in
"red-flagged" PRC companies -- material from a political optics standpoint but immaterial
(less than 0.02%) relative to $12.6T total AUM. BlackRock has a China mutual fund license (via
its WFOE) but this is early-stage and contributes negligible revenue. The tariff/trade war
impact is indirect -- market declines in Chinese/EM equities reduce AUM and therefore fees,
but given the small allocation the effect is modest.
Key catalysts (bull case)
| # |
Catalyst |
Detail |
Probability |
| 1 |
Q1 2026 Earnings (Apr 14 BMO) |
Flow momentum from Q4 ($281B net inflows) likely continued. Imminent catalyst. |
High |
| 2 |
GIP/HPS/Preqin integration |
Private markets AUM targeting $400B by 2030. Revenue synergies ramping. Higher-fee mix (~1.5-2% vs ETF ~0.10-0.20%). |
High |
| 3 |
ETF share class rule change |
SEC considering allowing ETF share classes for mutual funds. BLK is the #1 beneficiary as the dominant ETF provider. |
Medium |
| 4 |
Aladdin Copilot (AI) |
Generative AI interface could expand Aladdin TAM and margins. H2 2026 timing. |
Medium |
| 5 |
Insurance channel expansion |
~5% of AUM today, growing via HPS private credit integration. |
High |
| 6 |
Active ETF growth |
Fastest-growing ETF segment; BLK gaining share. |
High |
Key risks (bear case)
| # |
Risk |
Severity |
Detail |
| 1 |
Market correction / AUM decline |
HIGH |
Beta of 1.49. A 10% equity decline reduces AUM by ~$500B, translating to ~$500-700M annualized fee loss. AUM at record $14T+ means fees also at record levels. |
| 2 |
Integration risk (GIP/HPS/Preqin) |
MEDIUM |
Three simultaneous acquisitions ($12.5B + $12B + $3.2B) are unprecedented for BLK. Key person departures, client retention, tech integration all at risk. Q4 GAAP margin compressed to 23.7%. |
| 3 |
Macro / recession |
MEDIUM |
Goldman Sachs estimates 40-50% recession probability over next 12 months. AUM declines from market drawdowns plus net outflows in risk-off create a double hit. |
| 4 |
ESG/anti-ESG litigation |
LOW-MED |
13 Republican-led states filed antitrust suit (judge denied dismissal). Louisiana divested ~$794M. Actual AUM losses immaterial (less than 0.1%), but headline risk persists. |
| 5 |
Fee compression |
LOW-MED |
iShares core ETFs at 0.03-0.07% expense ratios. Blended base fee rate declining ~1-2 bps/year. Mitigated by private markets mix shift. |
| 6 |
China regulatory / political |
LOW |
Less than 2% of AUM. House CCP Committee flagged ~$1.9B in "red-flagged" PRC investments -- immaterial at less than 0.02% of total AUM. |
Scenario analysis
| Scenario |
Key Driver |
Implied Score |
Probability |
| Bull -- private markets + Aladdin AI + ETF rule change |
+1 bp fee rate = ~$1.4B rev |
8-9 |
25% |
| Base -- integration on track, markets stable |
$54.42 EPS, 17.8x P/E |
7 |
45% |
| Bear -- recession + 20% market decline + integration stumble |
AUM -$2-3T, fees -$2-3B |
3-4 |
30% |
Asymmetry skews modestly positive. The stock is -21% from its 52-week high,
with analyst targets of $1,257-$1,289 implying 30%+ upside. The bear case requires a
recession-driven market correction (40-50% probability per Goldman Sachs) combined with
integration execution failure -- a compound probability of roughly 15-20%. The bull case
benefits from multiple independent catalysts (private markets scaling, Aladdin AI, ETF rule
change) where any single catalyst can drive meaningful upside. China risk -- the dominant
concern for many equities -- is effectively a non-factor for BLK.
Score rationale
Score of 7/10 reflects a favorable risk/reward profile with manageable downside risks.
Positives: China exposure is negligible at less than 2% of AUM -- effectively insulated from tariff/trade war dynamics pressuring direct-exposure names (+1.5). Catalyst pipeline is robust and well-timed: GIP/HPS/Preqin integration shifts AUM mix toward higher-fee private markets, Aladdin Copilot introduces an AI growth vector, and the potential ETF share class rule change would be a structural windfall (+2). Q1 2026 earnings on April 14 represent an imminent catalyst with momentum from record Q4 inflows of $281B (+). Stock is -21% from 52-week highs, compressing the valuation premium to the lower end of its historical 50-100% range (+). Record $14T+ AUM with continued organic inflow momentum (+).
Negatives: Valuation premium to peers (~78% on forward P/E) is justified but leaves less margin of safety (-0.5). Market beta of 1.49 means BLK amplifies equity drawdowns, and AUM at record levels creates asymmetric downside risk in a correction (-1). Integration of three simultaneous acquisitions is unprecedented in scale (-0.5). ESG/anti-ESG litigation creates headline risk despite immaterial financial impact (-0.5). Fee compression is a structural headwind, though offset by alternatives mix shift (-0.5).
Net: The combination of minimal China risk, multiple near-term catalysts, and a stock price 21% off its highs justifies a score above the midpoint. Re-evaluate when: (1) Q1 2026 earnings confirm flow momentum, (2) integration milestones hit or miss in H1 2026, or (3) macro conditions deteriorate materially.
Data sourced from
Daloopa, StockAnalysis, GuruFocus, and earnings transcripts.